Loading...

Mi-Ok Kim, PhD

Title(s)Professor, Epidemiology & Biostatistics
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of Illinois at Urbana-Champaign, IllinoisPhD2003Statistics
    University of Illinois at Urbana-Champaign, IllinoisMS2003Statistics
    Collapse Awards and Honors
    Crohn’s and Colitis Foundation of America2017Crohn’s and Colitis Foundation Uniting to Care and Cure Award

    Collapse Overview 
    Collapse Overview
    I am Professor of the Division of Biostatistics at UCSF and Director of the Helen Diller Family Comprehensive Cancer Center Biostatistics Shared Resource Core. I have expertise in the development and use of statistical methods for adaptive clinical trial designs, semi- and non-parametric analysis of longitudinal and survival data, and causal inference using structured data. I have collaborated in cancer and inflammatory bowel disease research.

    Collapse Research 
    Collapse Research Activities and Funding
    Propensity Score-based Methods for CER Using Multilevel Data: What Works Best When
    PCORI ME-1403-13922Jan 1, 2015 - Jun 30, 2018
    Role: PI
    Risk Stratification & Identification of immunogenic and microbial markers of rapid disease progression in children with Crohn’s disease
    CCFA Research Initiative GrantJul 1, 2008 - Dec 31, 2018
    Role: Biostatistics Core Director
    Cancer Center Support Grant
    NIH/NCI P30 CA082103Aug 5, 1999 - May 31, 2023
    Role: Biostatistics Core Director

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Fletcher JS, Wu J, Jessen WJ, Pundavela J, Miller JA, Dombi E, Kim MO, Rizvi TA, Chetal K, Salomonis N, Ratner N. Cxcr3-expressing leukocytes are necessary for neurofibroma formation in mice. JCI Insight. 2019 Feb 07; 4(3). PMID: 30728335.
      View in: PubMed
    2. Hedberg ML, Peyser ND, Bauman JE, Gooding WE, Li H, Bhola NE, Zhu TR, Zeng Y, Brand TM, Kim MO, Jordan RCK, VandenBerg S, Olivas V, Bivona TG, Chiosea SI, Wang L, Mills GB, Johnson JT, Duvvuri U, Ferris RL, Ha P, Johnson DE, Grandis JR. Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA-altered head and neck cancer. J Exp Med. 2019 Jan 25. PMID: 30683736.
      View in: PubMed
    3. Krishnakumar C, Ballengee CR, Liu C, Kim MO, Baker SS, Baldassano RN, Cohen SA, Crandall WV, Denson LA, Dubinsky MC, Evans J, Gokhale R, Griffiths A, Guthery SL, Oliva-Hemker M, Heyman MB, Keljo D, Kellermayer R, Leleiko NS, Mack DR, Markowitz JF, Moulton DE, Noe JD, Otley AR, Patel AS, Pfefferkorn M, Rabizadeh S, Rosh JR, Snapper S, Walters TD, Ziring D, Mondal K, Kappelman MD, Hyams JS, Kugathasan S. Variation in Care in the Management of Children With Crohn's Disease: Data From a Multicenter Inception Cohort Study. Inflamm Bowel Dis. 2019 Jan 02. PMID: 30601983.
      View in: PubMed
    4. Kim MO, Zhou M.Size and Shape of Confidence Regions from Extended Empirical Likelihood Tests. Statistica Sinica. 2019; (29):371-386.
    5. Haberman Y, Schirmer M, Dexheimer PJ, Karns R, Braun T, Kim MO, Walters TD, Baldassano RN, Noe JD, Rosh J, Markowitz J, Crandall WV, Mack DR, Griffiths AM, Heyman MB, Baker SS, Kellermayer R, Moulton D, Patel AS, Gulati AS, Steiner SJ, LeLeiko N, Otley A, Oliva-Hemker M, Ziring D, Kirschner BS, Keljo DJ, Guthery SL, Cohen SA, Snapper S, Evans J, Dubinsky M, Aronow B, Hyams JS, Kugathasan S, Huttenhower C, Xavier RJ, Denson LA. Age-of-diagnosis dependent ileal immune intensification and reduced alpha-defensin in older versus younger pediatric Crohn Disease patients despite already established dysbiosis. Mucosal Immunol. 2019 Mar; 12(2):491-502. PMID: 30542108.
      View in: PubMed
    6. Fletcher JS, Springer MG, Choi K, Jousma E, Rizvi TA, Dombi E, Kim MO, Wu J, Ratner N. STAT3 inhibition reduces macrophage number and tumor growth in neurofibroma. Oncogene. 2018 Dec 12. PMID: 30542122.
      View in: PubMed
    7. Sayles LC, Breese MR, Koehne AL, Leung SG, Lee AG, Liu HY, Spillinger A, Shah AT, Tanasa B, Straessler K, Hazard FK, Spunt SL, Marina N, Kim GE, Cho SJ, Avedian RS, Mohler DG, Kim MO, DuBois SG, Hawkins DS, Sweet-Cordero EA. Genome-Informed Targeted Therapy for Osteosarcoma. Cancer Discov. 2019 Jan; 9(1):46-63. PMID: 30266815.
      View in: PubMed
    8. Kim HJ, Lu B, Nehus EJ, Kim MO. Estimating heterogeneous treatment effects for latent subgroups in observational studies. Stat Med. 2019 Feb 10; 38(3):339-353. PMID: 30232820.
      View in: PubMed
    9. Chandradevan R, Hofmekler T, Mondal K, Harun N, Venkateswaran S, Somineni HK, Ballengee CR, Kim MO, Griffiths A, Noe JD, Crandall WV, Snapper S, Rabizadeh S, Rosh JR, Walters TD, Bertha M, Dubinsky MC, Denson LA, Sauer CG, Markowitz JF, LeLeiko NS, Hyams JS, Kugathasan S. Evolution of Pediatric Inflammatory Bowel Disease Unclassified (IBD-U): Incorporated With Serological and Gene Expression Profiles. Inflamm Bowel Dis. 2018 Sep 15; 24(10):2285-2290. PMID: 29860529.
      View in: PubMed
    10. Ballengee CR, Stidham RW, Liu C, Kim MO, Prince J, Mondal K, Baldassano R, Dubinsky M, Markowitz J, Leleiko N, Hyams J, Denson L, Kugathasan S. Association Between Plasma Level of Collagen Type III alpha 1 Chain and Development of Strictures in Pediatric Patients With Crohn's Disease. Clin Gastroenterol Hepatol. 2018 Sep 10. PMID: 30213581.
      View in: PubMed
    11. Kim MO, Harun N, Liu C, Khoury JC, Broderick JP. Bayesian selective response-adaptive design using the historical control. Stat Med. 2018 Nov 20; 37(26):3709-3722. PMID: 29900577.
      View in: PubMed
    12. Wright SS, Trauernicht A, Bonkowski E, McCall CA, Maier EA, Bezold R, Lake K, Chalk C, Trapnell BC, Kim MO, Kugathasan S, Denson LA. Familial Association of Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2018 May; 66(5):767-772. PMID: 29216019.
      View in: PubMed
    13. Marigorta UM, Denson LA, Hyams JS, Mondal K, Prince J, Walters TD, Griffiths A, Noe JD, Crandall WV, Rosh JR, Mack DR, Kellermayer R, Heyman MB, Baker SS, Stephens MC, Baldassano RN, Markowitz JF, Kim MO, Dubinsky MC, Cho J, Aronow BJ, Kugathasan S, Gibson G. Transcriptional risk scores link GWAS to eQTLs and predict complications in Crohn's disease. Nat Genet. 2017 Oct; 49(10):1517-1521. PMID: 28805827.
      View in: PubMed
    14. Chien AJ, Chambers J, Mcauley F, Kaplan T, Letourneau J, Hwang J, Kim MO, Melisko ME, Rugo HS, Esserman LJ, Rosen MP. Erratum to: Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy. Breast Cancer Res Treat. 2017 08; 165(1):161. PMID: 28660429.
      View in: PubMed
    15. Nehus EJ, Liu C, Lu B, Macaluso M, Kim MO. Graft survival of pediatric kidney transplant recipients selected for de novo steroid avoidance-a propensity score-matched study. Nephrol Dial Transplant. 2017 Aug 01; 32(8):1424-1431. PMID: 28810723.
      View in: PubMed
    16. Chien AJ, Chambers J, Mcauley F, Kaplan T, Letourneau J, Hwang J, Kim MO, Melisko ME, Rugo HS, Esserman LJ, Rosen MP. Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy. Breast Cancer Res Treat. 2017 Aug; 165(1):151-159. PMID: 28503722.
      View in: PubMed
    17. Kugathasan S, Denson LA, Walters TD, Kim MO, Marigorta UM, Schirmer M, Mondal K, Liu C, Griffiths A, Noe JD, Crandall WV, Snapper S, Rabizadeh S, Rosh JR, Shapiro JM, Guthery S, Mack DR, Kellermayer R, Kappelman MD, Steiner S, Moulton DE, Keljo D, Cohen S, Oliva-Hemker M, Heyman MB, Otley AR, Baker SS, Evans JS, Kirschner BS, Patel AS, Ziring D, Trapnell BC, Sylvester FA, Stephens MC, Baldassano RN, Markowitz JF, Cho J, Xavier RJ, Huttenhower C, Aronow BJ, Gibson G, Hyams JS, Dubinsky MC. Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study. Lancet. 2017 04 29; 389(10080):1710-1718. PMID: 28259484.
      View in: PubMed
    18. Cho H, Kim S, Kim MO.Multiple quantile regression analysis of longitudinal data: Heteroscedasticity and efficient estimation. Journal of Multivariate Analysis. 2017; 155:334-343.
    19. Müller LU, Milsom MD, Kim MO, Schambach A, Schuesler T, Williams DA. Rapid Lentiviral Transduction Preserves the Engraftment Potential of Fanca-/- Hematopoietic Stem Cells. Mol Ther. 2008 Jun; 16(6):1154-1160. PMID: 28178472.
      View in: PubMed
    20. Dorris K, Liu C, Li D, Hummel TR, Wang X, Perentesis J, Kim MO, Fouladi M. A comparison of safety and efficacy of cytotoxic versus molecularly targeted drugs in pediatric phase I solid tumor oncology trials. Pediatr Blood Cancer. 2017 03; 64(3). PMID: 27654490.
      View in: PubMed
    21. Ciricillo J, Haslam D, Blum S, Kim MO, Liu C, Paulsen G, Courter J, Danziger-Isakov L. Frequency and risks associated with Clostridium difficile-associated diarrhea after pediatric solid organ transplantation: a single-center retrospective review. Transpl Infect Dis. 2016 Oct; 18(5):706-713. PMID: 27492796.
      View in: PubMed
    22. Kim MO, Wang X, Liu C, Dorris K, Fouladi M, Song S. Random-effects meta-analysis for systematic reviews of phase I clinical trials: Rare events and missing data. Res Synth Methods. 2017 Jun; 8(2):124-135. PMID: 27285532.
      View in: PubMed
    23. Minar P, Saeed SA, Afreen M, Kim MO, Denson LA. Practical Use of Infliximab Concentration Monitoring in Pediatric Crohn Disease. J Pediatr Gastroenterol Nutr. 2016 05; 62(5):715-22. PMID: 26551317; PMCID: PMC4842082 [Available on 05/01/17].
    24. Cho H, Hong HG, Kim MO. Efficient quantile marginal regression for longitudinal data with dropouts. Biostatistics. 2016 07; 17(3):561-75. PMID: 26951723.
      View in: PubMed
    25. Wu J, Keng VW, Patmore DM, Kendall JJ, Patel AV, Jousma E, Jessen WJ, Choi K, Tschida BR, Silverstein KA, Fan D, Schwartz EB, Fuchs JR, Zou Y, Kim MO, Dombi E, Levy DE, Huang G, Cancelas JA, Stemmer-Rachamimov AO, Spinner RJ, Largaespada DA, Ratner N. Insertional Mutagenesis Identifies a STAT3/Arid1b/ß-catenin Pathway Driving Neurofibroma Initiation. Cell Rep. 2016 Mar 01; 14(8):1979-90. PMID: 26904939.
      View in: PubMed
    26. Kang J, Chan W, Kim MO, Steiner PM.Practice of Causal Inference with the Propensity of Being Zero or One: Assessing the Effect of Arbitrary Cutoffs of Propensity Scores. Communications for Statistical Applications and Methods. 2016; 23:1-20.
    27. Jousma E, Rizvi TA, Wu J, Janhofer D, Dombi E, Dunn RS, Kim MO, Masters AR, Jones DR, Cripe TP, Ratner N. Preclinical assessments of the MEK inhibitor PD-0325901 in a mouse model of Neurofibromatosis type 1. Pediatr Blood Cancer. 2015 Oct; 62(10):1709-16. PMID: 25907661; PMCID: PMC4546559 [Available on 10/01/16].
    28. Haberman Y, Tickle TL, Dexheimer PJ, Kim MO, Tang D, Karns R, Baldassano RN, Noe JD, Rosh J, Markowitz J, Heyman MB, Griffiths AM, Crandall WV, Mack DR, Baker SS, Huttenhower C, Keljo DJ, Hyams JS, Kugathasan S, Walters TD, Aronow B, Xavier RJ, Gevers D, Denson LA. Corrigendum. Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. J Clin Invest. 2015 Mar 02; 125(3):1363. PMID: 25729854; PMCID: PMC4362234.
    29. Haberman Y, Tickle TL, Dexheimer PJ, Kim MO, Tang D, Karns R, Baldassano RN, Noe JD, Rosh J, Markowitz J, Heyman MB, Griffiths AM, Crandall WV, Mack DR, Baker SS, Huttenhower C, Keljo DJ, Hyams JS, Kugathasan S, Walters TD, Aronow B, Xavier RJ, Gevers D, Denson LA. Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. J Clin Invest. 2014 Aug; 124(8):3617-33. PMID: 25003194; PMCID: PMC4109533.
    30. Minar P, Haberman Y, Jurickova I, Wen T, Rothenberg ME, Kim MO, Saeed SA, Baldassano RN, Stephens M, Markowitz J, Rosh J, Crandall WV, Heyman MB, Mack DR, Griffiths AM, Baker SS, Hyams JS, Kugathasan S, Denson LA. Utility of neutrophil Fc? receptor I (CD64) index as a biomarker for mucosal inflammation in pediatric Crohn's disease. Inflamm Bowel Dis. 2014 Jun; 20(6):1037-48. PMID: 24788216.
      View in: PubMed
    31. Kim MO, Liu C, Hu F, Lee JJ. Outcome-adaptive randomization for a delayed outcome with a short-term predictor: imputation-based designs. Stat Med. 2014 Oct 15; 33(23):4029-42. PMID: 24889540; PMCID: PMC4159410.
    32. Walters TD, Kim MO, Denson LA, Griffiths AM, Dubinsky M, Markowitz J, Baldassano R, Crandall W, Rosh J, Pfefferkorn M, Otley A, Heyman MB, LeLeiko N, Baker S, Guthery SL, Evans J, Ziring D, Kellermayer R, Stephens M, Mack D, Oliva-Hemker M, Patel AS, Kirschner B, Moulton D, Cohen S, Kim S, Liu C, Essers J, Kugathasan S, Hyams JS. Increased effectiveness of early therapy with anti-tumor necrosis factor-a vs an immunomodulator in children with Crohn's disease. Gastroenterology. 2014 Feb; 146(2):383-91. PMID: 24162032.
      View in: PubMed
    33. Marsh RA, Kim MO, Liu C, Bellman D, Hart L, Grimley M, Kumar A, Jodele S, Myers KC, Chandra S, Leemhuis T, Mehta PA, Bleesing JJ, Davies SM, Jordan MB, Filipovich AH. An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis. Biol Blood Marrow Transplant. 2013 Nov; 19(11):1625-31. PMID: 24035782; PMCID: PMC4167781.
    34. Krueger DA, Wilfong AA, Holland-Bouley K, Anderson AE, Agricola K, Tudor C, Mays M, Lopez CM, Kim MO, Franz DN. Everolimus treatment of refractory epilepsy in tuberous sclerosis complex. Ann Neurol. 2013 Nov; 74(5):679-87. PMID: 23798472.
      View in: PubMed
    35. Rose SR, Kim MO, Korbee L, Wilson KA, Ris MD, Eyal O, Sherafat-Kazemzadeh R, Bollepalli S, Harris R, Jeng MR, Williams DA, Smith FO. Oxandrolone for the treatment of bone marrow failure in Fanconi anemia. Pediatr Blood Cancer. 2014 Jan; 61(1):11-9. PMID: 24019220.
      View in: PubMed
    36. Dykes DM, Towbin AJ, Bonkowski E, Chalk C, Bezold R, Lake K, Kim MO, Heubi JE, Trapnell BC, Podberesky DJ, Denson LA. Increased prevalence of luminal narrowing and stricturing identified by enterography in pediatric Crohn's disease patients with elevated granulocyte-macrophage colony stimulating factor autoantibodies. Inflamm Bowel Dis. 2013 Sep; 19(10):2146-54. PMID: 23893081.
      View in: PubMed
    37. Gathungu G, Kim MO, Ferguson JP, Sharma Y, Zhang W, Ng SM, Bonkowski E, Ning K, Simms LA, Croft AR, Stempak JM, Walker N, Huang N, Xiao Y, Silverberg MS, Trapnell B, Cho JH, Radford-Smith GL, Denson LA. Granulocyte-macrophage colony-stimulating factor autoantibodies: a marker of aggressive Crohn's disease. Inflamm Bowel Dis. 2013 Jul; 19(8):1671-80. PMID: 23749272.
      View in: PubMed
    38. Jessen WJ, Miller SJ, Jousma E, Wu J, Rizvi TA, Brundage ME, Eaves D, Widemann B, Kim MO, Dombi E, Sabo J, Hardiman Dudley A, Niwa-Kawakita M, Page GP, Giovannini M, Aronow BJ, Cripe TP, Ratner N. MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors. J Clin Invest. 2013 Jan; 123(1):340-7. PMID: 23221341; PMCID: PMC3533264.
    39. Marsh RA, Rao K, Satwani P, Lehmberg K, Müller I, Li D, Kim MO, Fischer A, Latour S, Sedlacek P, Barlogis V, Hamamoto K, Kanegane H, Milanovich S, Margolis DA, Dimmock D, Casper J, Douglas DN, Amrolia PJ, Veys P, Kumar AR, Jordan MB, Bleesing JJ, Filipovich AH. Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes. Blood. 2013 Feb 07; 121(6):877-83. PMID: 23131490.
      View in: PubMed
    40. Chima RS, Daniels RC, Kim MO, Li D, Wheeler DS, Davies SM, Jodele S. Improved outcomes for stem cell transplant recipients requiring pediatric intensive care. Pediatr Crit Care Med. 2012 Nov; 13(6):e336-42. PMID: 22791094.
      View in: PubMed
    41. Prada CE, Jousma E, Rizvi TA, Wu J, Dunn RS, Mayes DA, Cancelas JA, Dombi E, Kim MO, West BL, Bollag G, Ratner N. Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition. Acta Neuropathol. 2013 Jan; 125(1):159-68. PMID: 23099891; PMCID: PMC3547628.
    42. Choi D, Hoffman KA, Kim MO, McCarty D. A high-resolution analysis of process improvement: use of quantile regression for wait time. Health Serv Res. 2013 Feb; 48(1):333-47. PMID: 22716460; PMCID: PMC3449006.
    43. Hoskins EE, Morreale RJ, Werner SP, Higginbotham JM, Laimins LA, Lambert PF, Brown DR, Gillison ML, Nuovo GJ, Witte DP, Kim MO, Davies SM, Mehta PA, Butsch Kovacic M, Wikenheiser-Brokamp KA, Wells SI. The fanconi anemia pathway limits human papillomavirus replication. J Virol. 2012 Aug; 86(15):8131-8. PMID: 22623785; PMCID: PMC3421690.
    44. Zhou M, Kim MO and Bathke A.Empirical Likelihood Analysis for the Heteroscedastic Accelerated Failure Time Model. Statistica Sinica. 2012; 22:295-316.
    45. Kim MO.Journal of Agricultural, Biological, and Environmental Statistics. Claus Thorn Ekstrom and Helle Sorensen: Statistical Data Analysis for the Life Sciences. 2012; 17(4):702–703 .
    46. Kim MO, Zhou M, Jeong JH. Censored quantile regression for residual lifetimes. Lifetime Data Anal. 2012 Apr; 18(2):177-94. PMID: 22183141.
      View in: PubMed
    47. Kim MO, Yang Y. Semiparametric Approach to a Random Effects Quantile Regression Model. J Am Stat Assoc. 2011 Dec 01; 106(496):1405-1417. PMID: 22347760.
      View in: PubMed
    48. Sundaram N, Bennett M, Wilhelm J, Kim MO, Atweh G, Devarajan P, Malik P. Biomarkers for early detection of sickle nephropathy. Am J Hematol. 2011 Jul; 86(7):559-66. PMID: 21630304; PMCID: PMC4167419.
    49. Nylund CM, D'Mello S, Kim MO, Bonkowski E, Däbritz J, Foell D, Meddings J, Trapnell BC, Denson LA. Granulocyte macrophage-colony-stimulating factor autoantibodies and increased intestinal permeability in Crohn disease. J Pediatr Gastroenterol Nutr. 2011 May; 52(5):542-8. PMID: 21502824.
      View in: PubMed
    50. George A, Benton J, Pratt J, Kim MO, Kalinyak KA, Kalfa TA, Joiner CH. The impact of the 2009 H1N1 influenza pandemic on pediatric patients with sickle cell disease. Pediatr Blood Cancer. 2011 Oct; 57(4):648-53. PMID: 21360656; PMCID: PMC4474377.
    51. Wu J, Dombi E, Jousma E, Scott Dunn R, Lindquist D, Schnell BM, Kim MO, Kim A, Widemann BC, Cripe TP, Ratner N. Preclincial testing of sorafenib and RAD001 in the Nf(flox/flox) ;DhhCre mouse model of plexiform neurofibroma using magnetic resonance imaging. Pediatr Blood Cancer. 2012 Feb; 58(2):173-80. PMID: 21319287; PMCID: PMC3128176.
    52. Marsh RA, Li D, Kim MO, Hart L, Joshi S, Jodele S, Mehta P, Jordan MB, Bleesing JJ, Davies SM, Filipovich AH.The Timing of Alemtuzumab Significantly Impacts Mixed Chimerism and Acute Graft Versus Host Disease. Biology of Blood and Marrow Transplantation. 2011; 17(2):S315.
    53. Mehta PA, Harris RE, Davies SM, Kim MO, Mueller R, Lampkin B, Mo J, Myers K, Smolarek TA. Numerical chromosomal changes and risk of development of myelodysplastic syndrome--acute myeloid leukemia in patients with Fanconi anemia. Cancer Genet Cytogenet. 2010 Dec; 203(2):180-6. PMID: 21156231.
      View in: PubMed
    54. Marsh RA, Vaughn G, Kim MO, Li D, Jodele S, Joshi S, Mehta PA, Davies SM, Jordan MB, Bleesing JJ, Filipovich AH. Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation. Blood. 2010 Dec 23; 116(26):5824-31. PMID: 20855862.
      View in: PubMed
    55. Crombleholme TM, Lim FY, Habli M, Polzin W, Jaekle R, Michelfelder E, Cnota J, Liu C, Kim MO. Improved recipient survival with maternal nifedipine in twin-twin transfusion syndrome complicated by TTTS cardiomyopathy undergoing selective fetoscopic laser photocoagulation. Am J Obstet Gynecol. 2010 Oct; 203(4):397.e1-9. PMID: 20723877.
      View in: PubMed
    56. Brown NM, Belles CA, Lindley SL, Zimmer-Nechemias L, Witte DP, Kim MO, Setchell KD. Mammary gland differentiation by early life exposure to enantiomers of the soy isoflavone metabolite equol. Food Chem Toxicol. 2010 Nov; 48(11):3042-50. PMID: 20691242.
      View in: PubMed
    57. Denson LA, Kim MO, Bezold R, Carey R, Osuntokun B, Nylund C, Willson T, Bonkowski E, Li D, Ballard E, Collins M, Moyer MS, Klein DJ. A randomized controlled trial of growth hormone in active pediatric Crohn disease. J Pediatr Gastroenterol Nutr. 2010 Aug; 51(2):130-9. PMID: 20453679; PMCID: PMC2910806.
    58. Liu C, Cripe TP, Kim MO. Statistical issues in longitudinal data analysis for treatment efficacy studies in the biomedical sciences. Mol Ther. 2010 Sep; 18(9):1724-30. PMID: 20588256; PMCID: PMC2956920.
    59. Brown NM, Belles CA, Lindley SL, Zimmer-Nechemias LD, Zhao X, Witte DP, Kim MO, Setchell KD. The chemopreventive action of equol enantiomers in a chemically induced animal model of breast cancer. Carcinogenesis. 2010 May; 31(5):886-93. PMID: 20110282; PMCID: PMC2864409.
    60. Marsh RA, Villanueva J, Kim MO, Zhang K, Marmer D, Risma KA, Jordan MB, Bleesing JJ, Filipovich AH. Patients with X-linked lymphoproliferative disease due to BIRC4 mutation have normal invariant natural killer T-cell populations. Clin Immunol. 2009 Jul; 132(1):116-23. PMID: 19398375; PMCID: PMC2729708.
    61. Milsom MD, Schiedlmeier B, Bailey J, Kim MO, Li D, Jansen M, Ali AM, Kirby M, Baum C, Fairbairn LJ, Williams DA. Ectopic HOXB4 overcomes the inhibitory effect of tumor necrosis factor-{alpha} on Fanconi anemia hematopoietic stem and progenitor cells. Blood. 2009 May 21; 113(21):5111-20. PMID: 19270262; PMCID: PMC2686182.
    62. Bathke A, Kim, MO, Zhou M.Combined multiple testing by censored empirical likelihood. Journal of Statistical Planning and Inference. 2009; 139:814-827.
    63. Han X, Uchida K, Jurickova I, Koch D, Willson T, Samson C, Bonkowski E, Trauernicht A, Kim MO, Tomer G, Dubinsky M, Plevy S, Kugathsan S, Trapnell BC, Denson LA. Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease. Gastroenterology. 2009 Apr; 136(4):1261-71, e1-3. PMID: 19230854.
      View in: PubMed
    64. Garfinkle JS, Cunningham LL, Beeman CS, Kluemper GT, Hicks EP, Kim MO. Evaluation of orthodontic mini-implant anchorage in premolar extraction therapy in adolescents. Am J Orthod Dentofacial Orthop. 2008 May; 133(5):642-53. PMID: 18456137.
      View in: PubMed
    65. Johansson G, Mahller YY, Collins MH, Kim MO, Nobukuni T, Perentesis J, Cripe TP, Lane HA, Kozma SC, Thomas G, Ratner N. Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors. Mol Cancer Ther. 2008 May; 7(5):1237-45. PMID: 18483311; PMCID: PMC2855168.
    66. Müller LU, Milsom MD, Kim MO, Schambach A, Schuesler T, Williams DA. Rapid lentiviral transduction preserves the engraftment potential of Fanca(-/-) hematopoietic stem cells. Mol Ther. 2008 Jun; 16(6):1154-60. PMID: 18398427.
      View in: PubMed
    67. Kim MO, Zhou M.Empirical Likelihood for Linear Models in the Presence of Nuisance Parameters. Statistics and Probability Letters. 2008; 78(12):1445-1451.
    68. Sherafat-Kazemzadeh R, Mehta SN, Care MM, Kim MO, Williams DA, Rose SR. Small pituitary size in children with Fanconi anemia. Pediatr Blood Cancer. 2007 Aug; 49(2):166-70. PMID: 17274008.
      View in: PubMed
    69. Kim MO.Quantile Regression with Varying Coefficients. Annals of Statistics. 2007; 35(1):92-108.
    70. Kim MO.Quantile Regression with Shape-Constrained Varying Coefficients. Sankhya: The Indian Journal of Statistics. 2006; 68(3):369-391.
    71. He X, Kim MO.On Marginal Estimation in a Semiparametric Model for Longitudinal Data with Time-Independent Covariates. Metrika. 2002; 55(1-2):67-74.